Perspective Therapeutics Inc (CATX)
$1.15 -1.71% Close Oct 30, 2026 Live
Perspective Therapeutics stock today
Perspective Therapeutics closed at $1.15 on October 30, 2026, down 1.71% on the day. Over the past year it returned -56.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $131 million.
$2.00$4.00
NovJan 2026MarMayJulSep
| Period | CATX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -58.2% | -0.9% |
| 3 months | -61.5% | +2.1% |
| Year to date | -58.2% | +11.7% |
| 1 year | -56.4% | +12.4% |
| 3 years | -55.4% | +88.5% |
| 5 years | -81.0% | +76.0% |
Key statistics
- Market value
- $131M
- Price / sales
- 320.3
- 52-week range
- $1.15 to $5.65
- Next report
- Nov 9, 2026 (estimated)
About Perspective Therapeutics
Biopharmaceutical company developing cancer and oncology treatments.
Sector: Health Care
More on Perspective Therapeutics
- Financials: revenue, earnings and segmentsRevenue -39% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $188.53 today
No forecast, no recommendation. This page describes Perspective Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.